Since 2005, scientists in the field of computer-aided drug design (CADD) across Asia have successfully organized ten editions of the Asia Hub for e-Drug Discovery (AHeDD) conference series. This event has evolved into a premier academic platform that brings together leading experts in drug design across Asia.
AHeDD 2025, the eleventh edition of the series, is scheduled to be held in Hangzhou, China. Hangzhou is not only a city that embodies the dynamism and aspirations of Asia but also a frontier hub where artificial intelligence and biomedicine exert a profound impact on the national economy.
The 10th AHeDD conference attracted over 100 participants, including numerous distinguished plenary and keynote speakers, as well as dozens of invited presenters. Notably, more than half of the attendees were graduate students and early-career researchers, who not only had the opportunity to learn from leading experts in the field but, for many, also presented their research for the first time.
The upcoming AHeDD 2025 is expected to welcome 150 delegates and feature 20+ parallel sessions, plenary and keynote lectures, special events, exhibitions, as well as various forms of academic exchange, including keynote speeches, invited talks, oral presentations, and poster sessions.
The conference will focus on cutting-edge themes, including:
● Molecular Modeling and Dynamics Simulation
● Artificial Intelligence-Driven Drug Design
● Research on Novel Mechanisms/Targets for Diseases
● Big Data-Driven Drug Discovery
● Frontiers in Medicinal Chemistry Research
As a leading academic platform in drug design across Asia, AHeDD 2025 provides an invaluable opportunity for researchers to showcase their latest advancements. The conference not only serves as a gateway to the future of pharmaceutical sciences but also fosters the exchange of specialized knowledge, technological innovations, and professional networking among experts in the field.